Navigation Links
Additional Radiotheraphy for Breast Cancer

Research says that giving extra radiotherapy to patients with early breast cancer significantly reduces the risk of cancer recurring in the breast. //The results were so clear that clinical practice should be changed immediately, particularly for younger women.

Nearly five thousand patients took part in the study. The majority of patients had undergone complete removal of their tumor. All the patients had 50Gy radiation to the whole breast and were randomised to receive either a 16Gy boost localised to the tumour bed area or no further radiotherapy. After a follow-up of over five years, only 109 patients in the booster group had suffered a recurrence.

It demonstrates clearly that a 16Gy boost significantly improves local control. Patients who had the boost had an overall local control rate of 95%, and survival at five years was 91%. The largest benefit was seen in women aged under 40, where the chances of recurrence were cut by 54%. Patients will be followed up for many years to see whether booster doses will also cut mortality.

These impressive results mean that a boost should now be considered the standard treatment for early breast cancer, particularly in younger women.
'"/>




Page: 1

Related medicine news :

1. Adding An Additional Drug May Help Patients With Glaucoma
2. Additional Responsiblities To Be Taken Up By Allied Healthcare Professionals
3. No More Additional Cases of Mad Cow Disease in Canada
4. NACO to Introduce 400 Additional AIDS/HIV Screening Centers
5. Analysis Shows Lamictal As An Effective Additional Therapy For Treatment of Grand Mal Seizures
6. Pressing Need for Additional Staff Consultants at NHS
7. NACO Inaugurates 37 Additional HIV Treatment Centers
8. Is Evidence-based Medicine Enough to Support Additional Research in Alternative Medicine?
9. Additional Research Imperative on Lung Cancer in Women
10. AIIMS Director Venugopal Removed from Additional Post
11. Consensus on "Combination Therapy" for Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events ... turn to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. ... tools for healthy coping following a traumatic event. , Trauma sufferers tend to feel ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out ... family verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers ... would throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
(Date:6/24/2016)... ... 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited to ... Recovery® program to drive cancer patients to and from their cancer treatments. Comfort ... quality of life and ongoing independence. Getting to and from medical treatments is ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... People across ... in Genome magazine’s Code Talker Award, an essay contest in which patients and their ... award to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... 2022" report to their offering. ... with kidney failure, it replaces the function of kidneys by ... and thus the treatment helps to keep the patient body,s ... Increasing number of ESRD patients & substantial healthcare ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
Breaking Medicine Technology: